HeartBeam, Inc (BEAT) – Business Wire
-
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
-
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
-
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
-
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG
-
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
-
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time
-
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights
-
HeartBeam Reports Third Quarter 2023 Financial Results
-
HeartBeam Announces Expansion of Its Scientific Advisory Board
-
HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias
-
HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time
-
HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team
-
HeartBeam Reports Second Quarter 2023 Financial Results
-
HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks
-
HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs
-
HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time
-
HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors
-
HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors
-
HeartBeam Enters into Strategic Alliance Agreement with Samsung
-
HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System
-
HeartBeam Announces FDA Submission of HeartBeam AIMIGo™ VECG System
-
HeartBeam Reports First Quarter 2023 Financial Results
-
HeartBeam Reports Fourth Quarter and Full Year 2022 Financial Results
-
HeartBeam Announces Acquisition of LIVMOR Assets
-
HeartBeam Announces Senior Leadership Change
-
HeartBeam to Host Fourth Quarter and Full Year 2022 Results Conference Call on Thursday March 16, 2023 at 4:30 p.m. Eastern Time
-
HeartBeam Appoints Robert Eno as President
-
HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
-
HeartBeam Issues Shareholder Letter and Provides Corporate Update
-
HeartBeam Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device
-
New HeartBeam Patent for 12-Lead Electrocardiogram (ECG) Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias
-
HeartBeam Reports Third Quarter 2022 Financial Results
-
HeartBeam to Host Third Quarter 2022 Results Conference Call on Thursday November 10, 2022 at 4:30 p.m. Eastern Time
-
HeartBeam to Present at LD Micro Main Event XV Conference
-
HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer
-
HeartBeam Broadens Product Portfolio Pipeline with Smartwatch Connectivity Enablement for 24/7 Heart Monitoring Solution
-
HeartBeam to Present at Upcoming Investor Conferences
-
HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
-
HeartBeam Launches New Video Showcasing the HeartBeam AIMI™ and AIMIGo™ Technologies
-
HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias
-
HeartBeam to Host Virtual Roadshow Webinar on Tuesday September 20, 2022 at 4:30 p.m. Eastern Time
-
HeartBeam Announces FDA Submission of HeartBeam AIMI™ Product
-
HeartBeam Reports Second Quarter 2022 Financial Results
-
HeartBeam Names Ken Persen as Chief Technology Officer
-
HeartBeam Wins CVI 2022 Innovation Summit Award
-
HeartBeam to Host Second Quarter 2022 Results Conference Call on Thursday August 11, 2022 at 4:30 p.m. Eastern Time
-
HeartBeam Expands Patient Population for Emergency Department Software Technology Solution
-
HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022
-
HeartBeam to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022
-
HeartBeam Reports First Quarter 2022 Financial Results
Back to BEAT Stock Lookup
